Florida Anti-Kickback Statute Defense: What a Recent DME Plea Tells You About Federal Exposure in 2026
A Florida DME owner walked into a Boston federal courtroom in late January 2026 and pleaded guilty to conspiracy to violate the federal Anti-Kickback Statute. He was charged in December. Two months later he is a felon facing up to ten years, False Claims Act exposure, and near-certain exclusion from federal health care programs. The Anti-Kickback Statute is the single most active fraud theory in federal healthcare enforcement, and Florida is the busiest district pipeline in the country.
The January 2026 DME plea was prosecuted in the District of Massachusetts based on Florida companies and offshore call-center marketing flows. Florida DME owners, telehealth operators, pharmacy operators, and physicians can and do receive indictments from districts far outside South Florida. If you have received an HHS-OIG subpoena, a grand jury subpoena, a Civil Investigative Demand, or a target letter, this is the window that matters.

A January 2026 federal plea in Massachusetts anchored to Florida DME companies shows how the government builds Anti-Kickback Statute cases across district lines.
What Actually Happened in the Recent Florida AKS Plea
The defendant owned two Florida DME companies between March 2020 and April 2022. He paid telemarketers and offshore call centers on a per-order basis to extract Medicare beneficiary information and generate orders for back, knee, wrist, and ankle braces. The orders were structured to look like a treating practitioner had prescribed the DME. Many were medically unnecessary. The per-order payment structure is what converted an ordinary marketing relationship into a federal conspiracy under 42 U.S.C. § 1320a-7b. The HHS-OIG enforcement release and the DOJ press release lay out the conduct.
Two things stand out. The DOJ takedowns get headlines for billion-dollar loss numbers, but the working volume of AKS prosecutions runs in the $1 million to $30 million band: single owner-operators and a handful of marketing partners. Second, this Florida defendant was charged out of Massachusetts. Federal prosecutors routinely indict where the call center, laboratory, or key cooperator sits, not where the defendant lives. A Florida DME or telehealth owner can wake up to an indictment from the Eastern District of New York, the District of Massachusetts, the Southern District of Texas, or any district whose investigators built the file.

What the Government Is Building
The Florida Strike Force, run jointly by Main Justice and the U.S. Attorneys' Offices in the Southern District of Florida and the Middle District of Florida, is paired with HHS-OIG, FBI, DEA, and state Medicaid Fraud Control Units. The unit pulls Medicare and Medicaid billing data, flags outlier patterns by NPI and Tax ID, and works backward from the claims to the marketing arrangements that generated them. By the time agents knock, the government has the bank wires, the email traffic, the call-center scripts, and the patient files.
In the 2025 National Health Care Fraud Enforcement Action, DOJ charged 324 defendants for $14.6 billion in alleged fraud nationally. Florida defendants accounted for 73 of those charges. The 2026 posture is heavier still. DOJ stood up a West Coast Strike Force in April and a National Fraud Enforcement Division earlier the same month. The Florida pipeline has not slowed.
The conduct categories drawing the most attention: telemedicine fraud involving orthotic and genetic testing orders, DME fraud involving per-order marketing arrangements, substance abuse treatment fraud involving sober-home patient brokering, pharmacy fraud involving compound and specialty drugs, and laboratory marketing through 1099 sales representatives paid on commission tied to volume.
Florida AKS Exposure and Charges
The federal Anti-Kickback Statute defense world runs on 42 U.S.C. § 1320a-7b. The statute makes it a felony to knowingly and willfully offer, pay, solicit, or receive remuneration, in cash or in kind, in exchange for referrals or orders reimbursable by a federal health care program. The AKS itself carries ten years per count and $100,000 fines.
The government stacks the AKS with companion charges to maximize sentencing exposure:
- 42 U.S.C. § 1320a-7b (Anti-Kickback): up to 10 years per count, $100,000 fine
- 18 U.S.C. § 1347 (Healthcare Fraud): up to 10 years, 20 where serious bodily injury alleged
- 18 U.S.C. § 1349 (Conspiracy): full statutory maximum of the underlying offense
- 18 U.S.C. § 1956 (Money Laundering): up to 20 years per count
- 31 U.S.C. § 3729 (False Claims Act): treble damages and per-claim penalties in parallel civil action
- 42 U.S.C. § 1320a-7 (Exclusion): permissive and mandatory exclusion from Medicare, Medicaid, TRICARE; Civil Monetary Penalties of $50,000 per violation plus three times the remuneration paid
Florida adds an entire state-law layer. The Florida Anti-Kickback Statute at Fla. Stat. § 456.054 prohibits any kickback by a provider for referrals. Violations cross-reference the Patient Brokering Act at § 817.505, a third-degree felony that ramps to first-degree felony exposure as volume and dollar value increase. The state Medicaid Provider Fraud statute at § 409.920 is its own felony track, prosecuted by the Florida Attorney General's Medicaid Fraud Control Unit, often in tandem with federal counts.
Practical exposure for most owner-operator AKS defendants in Florida runs in the 70 to 135 month guideline range before any 5K1.1 cooperation departure or 3553(a) variance, depending on loss amount, role, sophistication, and vulnerable-victim adjustments. Loss matters more than count.
Critical Mistakes People Make Early
The avoidable mistakes show up in nearly every AKS file, in the window between the first sign of investigation and indictment, when the case still has real shape-shifting potential.
Talking to agents without counsel. HHS-OIG and FBI agents who knock on a Florida physician's office or DME owner's house are there to lock in admissions. Statements at the door, in the driveway, or in the kitchen are admissible and will be used at sentencing.
Producing documents without a privilege review and litigation hold. Responding to a grand jury subpoena or HHS-OIG subpoena without a thorough privilege review locks in admissions and waives protection.
Assuming the investigation is not serious because no charges have been filed. The pre-indictment phase is where the government decides whether to charge a felony or settle civilly, whether to indict the owner or the marketer, whether to bring money laundering counts, and whether to seek pretrial restraint on assets. None of those decisions are visible from outside. All are still movable from inside.
Waiting for the target letter. By the time a target letter arrives, the case is more than ninety percent built. The real marker for engaging a federal target letter attorney is a subject-of-investigation letter, an HHS-OIG subpoena, a grand jury subpoena, or a False Claims Act Civil Investigative Demand.
Trying to restructure mid-investigation. Modifying marketing arrangements while under investigation creates obstruction exposure on top of the AKS counts.
Strategic Defense Approach
Real defense work on an AKS file is built around four questions: can the government prove willfulness, can it prove the remuneration crossed the statutory line, can its loss number survive scrutiny, and does the client cooperate or litigate.
Willfulness is the AKS Achilles heel. The statute requires that the defendant acted with knowledge that the conduct was unlawful, a higher mens rea than ordinary "knowingly." The HHS-OIG safe harbor regulations at 42 C.F.R. § 1001.952 describe specific compensation arrangements that, if structured correctly, do not violate the statute. Failure to fall inside a safe harbor is not the same as a violation, and the government routinely conflates the two.
Remuneration is the second pressure point. Per-order payments and percentage-of-revenue arrangements are nearly always indefensible. Flat-fee structures, fair market value compensation tied to legitimate services, and bona fide employment relationships often are. Stark Law violation defense work for physician self-referral cases layers on top of the AKS analysis.
Loss amount control is the third. Federal sentencing exposure is driven by loss under USSG § 2B1.1, and the government's first loss number is almost always inflated. Cutting the loss number from $5 million to $1.5 million can be the difference between 60 months and 24, sometimes between prison and probation. That work happens in PSR objections, but the groundwork is laid pre-indictment.
The cooperation-versus-litigation call is the fourth and must be made early. A reverse proffer, sitting down to hear what the government has before deciding which way to go, is one of the most undervalued tools in federal practice.

Why Timing Matters
The decisions that determine the outcome of a Florida AKS case happen in the months before the indictment, not after. By the time a defendant is arraigned, the prosecutor has already decided what counts to bring, what loss number to allege, whether to indict co-conspirators, and whether to seek forfeiture of bank accounts, homes, and vehicles.
The window between an HHS-OIG subpoena and indictment is typically six to eighteen months. The window between a target letter and indictment is typically thirty to ninety days. The earlier a pre-indictment defense lawyer is in the file, the more the case can still be shaped.
For Florida providers, the state-level layer is its own clock. Florida licensing boards open parallel investigations as soon as a federal subpoena becomes public. Coordinating the federal defense with the state administrative defense is what keeps a license intact through the criminal process.
Facing a Florida Anti-Kickback Statute Investigation?
AMC Defense Law represents physicians, DME owners, pharmacy operators, telemedicine executives, marketers, and entities in federal Anti-Kickback Statute investigations and prosecutions across Florida and nationwide. The firm handles matters at the HHS-OIG subpoena and target letter stage, through indictment, trial, and sentencing.
The cases that get resolved well are the ones where defense counsel is engaged pre-indictment, at the subpoena or target letter stage, not after the search warrant.

Aaron M. Cohen represents DME owners, physicians, pharmacy operators, and telemedicine executives in federal Anti-Kickback Statute investigations and prosecutions across Florida and nationwide.
If you or your loved ones have been arrested or are under federal investigation for Anti-Kickback Statute violations, healthcare fraud, or any related federal charge, call Aaron M. Cohen, 24 hours a day to get help. Request a confidential consultation.

Aaron M. Cohen
Principal Attorney
Aaron M. Cohen is a nationally recognized criminal defense attorney with over 30 years of experience representing individuals and entities in complex criminal investigations and prosecutions across the United States.
View Attorney ProfileRelated Analysis
DME and Telemedicine Fraud: Why Physicians Are Now the Primary Federal Targets
DOJ charged 96 medical professionals in the 2025 takedown. The COVID telehealth boom created a paper trail prosecutors are now using against the doctors who signed.
DOJ Built a New Healthcare Fraud Machine for 2026. Florida Providers Need to Pay Attention.
Florida healthcare providers face a DOJ fraud machine built for telehealth, kickback, and billing cases. Learn where the new exposure starts before agents call.
$1 Billion Telemedicine Conviction in the Southern District of Florida: What the HealthSplash Verdict Signals for Telehealth Operators, DME Suppliers, and Marketing Companies
The HealthSplash verdict shows DOJ is charging the platform builders behind telemedicine and DME schemes, not just the doctors and suppliers downstream.